-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US2075231017 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 132M |
|---|---|
| PE Ratio | None |
| Beta | -0.18 |
| Target Price | 7.9 |
| Dividend Yield | None |
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CNTB using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026